The trial is a multi-center 1,200-patient study in the first-line treatment of patients with metastatic colorectal cancer. Patients will be equally randomized to two arms containing either CoFactor
Abraxis will have agreements with most major group purchasing organizations, representing the majority of US hospitals, and will assume responsibility for over 700 individual contracts for this portfolio
In October 2004, Angiotech's surgical specialties division and Quill entered into an exclusive manufacturing and distribution agreement for the Contour Threads product line to be used in minimally-invasive
Chimerix will initiate a single-site phase I clinical trial to evaluate the safety of CMX001 in healthy volunteers. CMX001 is an oral antiviral drug candidate to be evaluated
Glumetza is a once-daily extended-release formulation of metformin for the treatment of patients with type 2 diabetes that Depomed developed utilizing its proprietary AcuForm drug delivery technology. Under
The FDA accepted EntreMed's application upon review of data from in vitro studies in glioma cell lines that demonstrate the antiproliferative activity of Panzem (2-methoxyestradiol, or 2ME2). Additionally,
CoTherix has also acquired exclusive rights to develop and commercialize oral formulations of Fasudil for the treatment of stable angina in the same territories. Under the terms of
The results of the trial of Nymox's lead drug candidate for the treatment of benign prostatic hyperplasia (BPH), were reported during a recent review of safety data from
Jerusalem-based Intec will develop and manufacture the drug using the Accordion Pill technology, while California-based Impax will conduct clinical trials and commercialize the product. The financial terms of
Following the submission of its investigational new drug (IND) application to the Food and Drug Administration (FDA), the New Jersey-based company says it is now preparing for a
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.